Elite Pharmaceuticals, Inc. Accrued Liabilities, Current
Elite Pharmaceuticals, Inc. (ELTP) had Accrued Liabilities, Current of $6.43 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $6.43M.
- 2026-03-31: Accrued Liabilities, Current $10.19M.
- 2025-12-31: Accrued Liabilities, Current $5.55M.
- 2025-09-30: Accrued Liabilities, Current $6.15M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $6.43M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $10.19M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $5.55M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $6.15M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $4.58M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $3.80M 10-K · filed 2026-06-29 |
| 2024-12-31 | $3.72M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $5.70M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $6.23M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $5.30M 10-K · filed 2025-06-30 |
| 2023-12-31 | $11.88M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $11.16M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $5.93M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $5.05M 10-K · filed 2024-07-01 |
| 2022-12-31 | $4.68M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $4.58M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.81M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $4.69M 10-K · filed 2023-06-29 |
| 2021-12-31 | $4.03M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $3.78M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.94M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $4.27M 10-K · filed 2022-06-29 |
| 2020-12-31 | $4.61M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $4.51M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $4.56M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $4.82M 10-K · filed 2021-06-14 |
| 2019-12-31 | $4.42M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $4.05M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.63M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $3.71M 10-K · filed 2020-06-29 |
| 2018-12-31 | $3.03M 10-Q · filed 2019-02-11 |
| 2018-09-30 | $2.66M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.97M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.79M 10-K · filed 2019-06-21 |
| 2017-12-31 | $1.79M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $1.34M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.20M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $794.63K 10-K · filed 2018-06-14 |
| 2016-12-31 | $1.80M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $1.43M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.40M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $555.35K 10-K · filed 2017-06-14 |
| 2015-03-31 | $614.00K 10-K · filed 2016-06-15 |